Gravar-mail: TMOD-38. EXTENT OF GLIOBLASTOMA INVASION PREDICTS OVERALL SURVIVAL FOLLOWING UPFRONT RADIOTHERAPY CONCURRENT WITH TEMOZOLOMIDE